International Tennis Federation bans Sharapova for two years after positive drug test
Friday, June 10, 2016
|The tribunal found that I did not seek treatment from my doctor for the purpose of obtaining a performance enhancing substance|
Sharapova said she was not aware of the ban and continued to take it after January 1 under a trade name, mildronate. Mildronate or meldonium is a heart disease drug, and Sharapova said she was consuming it for a decade, due to heart concerns and as some of her family members have been diagnosed with diabetes.
Five-time Grand Slam winner Sharapova lost toin this year's quarter-finals. The ban runs until January 26, 2018; she said she would appeal against it to the .
She posted on her Facebook account, "Today with their decision of a two year suspension, the ITF tribunal unanimously concluded that what I did was not intentional. The tribunal found that I did not seek treatment from my doctor for the purpose of obtaining a performance enhancing substance."
- "Maria Sharapova banned for two years for failed drugs test but will appeal" — , June 8, 2016
- Kevin Mitchell. "Maria Sharapova receives two-year ban for failing drug test" — , June 8, 2016
- Statement" — , June 8, 2016